TANG CAPITAL MANAGEMENT LLC Diversified Active

Location: San Diego, CA

CIK: 0001232621 · Show all filings

Period: Q4 2019 (← Previous) (Next →)

Filing Date: Feb 14, 2020

Total Value: $837M (100.0% shares, 0.0% debt)

Holdings (17)

— ODONATE THERAPEUTICS INC 54.6%

Value $457M Shares 14,075,269 Est. Cost $25.08 Unrealized —

HRTX HERON THERAPEUTICS INC 14.1%

Value $118M Shares 5,017,203 Est. Cost $14.10 Unrealized +56.9%

RCKT ROCKET PHARMACEUTICALS INC 8.1%

Value $67.49M Shares 2,965,485 Est. Cost $16.31 Unrealized +2.4%

RLMD RELMADA THERAPEUTICS INC 6.1%

Value $50.7M Shares 1,300,000 Est. Cost $28.22 Unrealized 0.0%

EOLS EVOLUS INC 3.8%

Value $32.07M Shares 2,635,000 Est. Cost $14.10 Unrealized 0.0%

ANAB ANAPTYSBIO INC 3.6%

Value $29.96M Shares 1,843,814 Est. Cost $23.65 Unrealized 0.0%

— AVROBIO INC 2.4%

Value $20.13M Shares 1,000,000 Est. Cost $15.15 Unrealized —

— LA JOLLA PHARMACEUTICAL CO 2.3%

Value $19.41M Shares 4,938,893 Est. Cost $15.94 Unrealized —

REGN REGENERON PHARMACEUTICALS 2.0%

Value $16.9M Shares 45,000 Est. Cost $334.59 Unrealized 0.0%

BMY BRISTOL MYERS SQUIBB CO 0.9%

Value $7.179M Shares 111,844 Est. Cost $45.19 Unrealized 0.0%

PRTA PROTHENA CORP PLC 0.8%

Value $6.709M Shares 423,823 Est. Cost $11.57 Unrealized -7.3%

— G1 THERAPEUTICS INC 0.5%

Value $4.493M Shares 170,000 Est. Cost $30.16 Unrealized —

PBYI PUMA BIOTECHNOLOGY INC 0.4%

Value $3.057M Shares 349,400 Est. Cost $30.17 Unrealized -72.6%

— IVERIC BIO INC 0.3%

Value $2.145M Shares 250,000 Est. Cost $1.30 Unrealized —

— NUCANA PLC 0.2%

Value $1.525M Shares 250,000 Est. Cost $7.24 Unrealized —

— BRISTOL MYERS SQUIBB CO 0.0%

Value $337K Shares 111,844 Est. Cost $3.01 Unrealized —

— EIDOS THERAPEUTICS INC 0.0%

Value $217K Shares 3,783 Est. Cost $57.36 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	ODONATE THERAPEUTICS INC	14,075,269	$457M	54.6%	$25.08	—	COM	676079106
HRTX	HERON THERAPEUTICS INC	5,017,203	$118M	14.1%	$14.10	+56.9%	COM	427746102
RCKT	ROCKET PHARMACEUTICALS INC	2,965,485	$67.49M	8.1%	$16.31	+2.4%	COM	77313F106
RLMD	RELMADA THERAPEUTICS INC	1,300,000	$50.7M	6.1%	$28.22	0.0%	COM	75955J402
EOLS	EVOLUS INC	2,635,000	$32.07M	3.8%	$14.10	0.0%	COM	30052C107
ANAB	ANAPTYSBIO INC	1,843,814	$29.96M	3.6%	$23.65	0.0%	COM	032724106
—	AVROBIO INC	1,000,000	$20.13M	2.4%	$15.15	—	COM	05455M100
—	LA JOLLA PHARMACEUTICAL CO	4,938,893	$19.41M	2.3%	$15.94	—	COM	503459604
REGN	REGENERON PHARMACEUTICALS	45,000	$16.9M	2.0%	$334.59	0.0%	COM	75886F107
BMY	BRISTOL MYERS SQUIBB CO	111,844	$7.179M	0.9%	$45.19	0.0%	COM	110122108
PRTA	PROTHENA CORP PLC	423,823	$6.709M	0.8%	$11.57	-7.3%	SHS	G72800108
—	G1 THERAPEUTICS INC	170,000	$4.493M	0.5%	$30.16	—	COM	3621LQ109
PBYI	PUMA BIOTECHNOLOGY INC	349,400	$3.057M	0.4%	$30.17	-72.6%	COM	74587V107
—	IVERIC BIO INC	250,000	$2.145M	0.3%	$1.30	—	COM	46583P102
—	NUCANA PLC	250,000	$1.525M	0.2%	$7.24	—	SPONSORED ADR	67022C106
—	BRISTOL MYERS SQUIBB CO	111,844	$337K	0.0%	$3.01	—	RIGHT 99/99/9999	110122157
—	EIDOS THERAPEUTICS INC	3,783	$217K	0.0%	$57.36	—	COM	28249H104